Corpus Intelligence IC Memo — BEHAVIORAL HEALTH OF ROCKY TOP LLC 2026-04-26 15:02 UTC
IC Memo — BEHAVIORAL HEALTH OF ROCKY TOP LLC
Investment Committee Memorandum | TN | 18 beds | Grade C | EBITDA uplift $119K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BEHAVIORAL HEALTH OF ROCKY TOP LLC

CCN 444028 | nan, TN | 18 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

BEHAVIORAL HEALTH OF ROCKY TOP LLC is a 18-bed under-performing / distressed in nan, TN with $1.4M in net patient revenue and a -33.3% operating margin. The hospital serves a payer mix of 46.9% Medicare, 0.6% Medicaid, and 52.5% commercial.

Thesis: Turnaround. Our ML models identify $119K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -33.3% to -24.8% (+852bps).

Net Revenue HCRIS$1.4M
Current EBITDA COMPUTED$-465K
Operating Margin COMPUTED-33.3%
Occupancy HCRIS23.7%
Revenue / Bed COMPUTED$78K
Net-to-Gross HCRIS43.1%
Distress Probability ML57.0%

2. Market Context & Competitive Position

141
TN Hospitals
-0.6%
State Median Margin
39
Comparable Hospitals

TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of -33.3% places it below the state median. Among 39 size-comparable peers (9-36 beds), the median margin is -0.6%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (9-36), prioritizing same-state peers. 39 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BEHAVIORAL HEALTH OF ROCKY TOP (Target)TN18$1.4M-33.3%
INDIAN PATH COMMUNITY HOSPITALTN35$142.8M12.0%
THE CENTER FOR SPINAL SURGERYTN23$78.7M39.3%
TRUSTPOINT HOSPITALTN18$50.8M-0.8%
VANDERBILT BEDFORD COUNTY HOSPTN24$49.5M1.9%
NEWPORT MEDICAL CENTERTN32$47.8M11.6%
FORT LOUDOUN MEDICAL CENTERTN30$41.3M10.0%
CLAIBORNE MEDICAL CENTERTN26$30.9M-9.9%
MARSHALL MEDICAL CENTERTN25$29.5M-28.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $119K (852bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Denial Rate Reduction12.0%6.5%$35K+252bp12mo
Net Collection Rate93.5%97.0%$29K+210bp18mo
Cost to Collect4.5%2.5%$28K+200bp12mo
A/R Days Reduction5200.0%3800.0%$17K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+69bp6mo

5. EBITDA Bridge

Denial Rate Reduction
$35K
Net Collection Rate
$29K
Cost to Collect
$28K
A/R Days Reduction
$17K
Clean Claim Rate
$10K
Total EBITDA Uplift$119K
Current EBITDA$-465K
+ RCM Uplift+$119K
Pro Forma EBITDA$-346K
Current Margin-33.3%
Pro Forma Margin-24.8%
WC Released (1x)$54K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-715K$-1.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-715K$-2.3M0.00x-100.0%
Bull Case9.0x11.0x$-644K$-2.1M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-644K$-2.5M0.00x-100.0%
Bear Case11.0x10.0x$-787K$-2.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-787K$-2.7M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 23.7%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 57.0% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 39 hospitals with 9-36 beds
  • Same-state prioritization (n=40)
  • Comp margins: P25=-14.3% / P50=-0.6% / P75=9.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.